GMRE Stock Analysis: Buy, Sell, or Hold?
GMRE - Global Medical REIT Inc.
$35.98
-0.01 (-0.03%)
âŧ
5d:
-0.5%
30d:
-0.08%
90d:
+11.08%
WAIT
LOW Confidence
Analysis Updated: Feb 20, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When GMRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GMRE is fairly priced but lacks strong directional signals. At 20.4% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GMRE is fairly priced but lacks strong directional signals. At 20.4% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GMRE is currently trading at $35.98, which is considered fair based on recent price action. From a valuation perspective, the stock is trading at a premium (Forward PE: 299.8) compared to its historical average (171.6). At these levels, the market is pricing in 20.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GMRE is in a strong uptrend. The price is currently testing key support at $35.51. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $40.86 (+13.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GMRE is in a strong uptrend. The price is currently testing key support at $35.51. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $40.86 (+13.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
48/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
65.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading below Wall St target ($40.86)
- NEUTRAL: PE elevated vs history but 20.4% growth expectation is conservative given 200% recent growth
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$35.51
Resistance Level
$37.67
Current Trend
Strong Uptrend
Technical data as of
Feb 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
299.83
Wall Street Target
$40.86
(+13.6%)
Revenue Growth (YoY)
8.6%
Earnings Growth (YoY)
200.0%
Profit Margin
1.7%
Valuation Premium vs History
+20.4% premium
PE vs Historical
299.8 vs 171.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+20.4%
(market-implied from PE analysis)
1-Year Target
$43.32
(+20%)
2-Year Target
$52.16
(+45%)
3-Year Target
$62.80
(+75%)
3-Yr Target (if PE normalizes)
(PE: 300â172)
PE COMPRESSION
$35.94
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 22, 2026 8:24 PM ET
Data refreshes hourly during market hours. Next update: 9:24 PM
Data refreshes hourly during market hours. Next update: 9:24 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GMRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$100 | 66 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$256 | 63 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$23 | 53 HOLD |
|
OHI
Omega Healthcare InvestoâĻ |
HOLD
16 analysts |
$52 | 77 BUY |
|
STRW
Strawberry Fields REIT LâĻ |
STRONG BUY
7 analysts |
$16 | 64 BUY |
